Home/Filings/4/0001209191-20-046502
4//SEC Filing

Kowalski Mark 4

Accession 0001209191-20-046502

CIK 0001290149other

Filed

Aug 11, 8:00 PM ET

Accepted

Aug 12, 9:36 PM ET

Size

5.6 KB

Accession

0001209191-20-046502

Insider Transaction Report

Form 4
Period: 2020-08-12
Kowalski Mark
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-08-12+24,97024,970 total
    Exercise: $12.15Exp: 2030-08-12Common Stock (24,970 underlying)
Footnotes (1)
  • [F1]The option vests as to 25% of the total shares on August 10, 2021, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on August 10, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Issuer

Sierra Oncology, Inc.

CIK 0001290149

Entity typeother

Related Parties

1
  • filerCIK 0001628357

Filing Metadata

Form type
4
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 9:36 PM ET
Size
5.6 KB